EDITAS MEDICINE, INC. Fair Value Adjustment of Warrants
EDITAS MEDICINE, INC. (EDIT) reported Fair Value Adjustment of Warrants of $87.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-03.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2017-03-03
- EDITAS MEDICINE, INC. fair value adjustment of warrants for the quarter ending 2016-12-31 was $0.00.
- EDITAS MEDICINE, INC. fair value adjustment of warrants for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- EDITAS MEDICINE, INC. fair value adjustment of warrants for the quarter ending 2016-06-30 was $0.00.
- EDITAS MEDICINE, INC. fair value adjustment of warrants for the quarter ending 2016-03-31 was $87.00K.
- EDITAS MEDICINE, INC. fair value adjustment of warrants for fiscal 2016 was $87.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $0.00 derived: sum of 2 quarters · filed 2017-03-03 | $0.00 derived: sum of 3 quarters · filed 2017-03-03 | $87.00K 10-K · filed 2017-03-03 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $0.00 derived: sum of 2 quarters · filed 2016-11-09 | $87.00K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | $87.00K 10-Q · filed 2016-08-10 | ||
| 2016-03-31 | $87.00K 10-Q · filed 2016-05-13 | |||
| 2015-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $92.00K 10-Q · filed 2016-11-09 | ||
| 2015-06-30 | $79.00K 10-Q · filed 2016-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |